Perivascular nerve fiber α-synuclein regulates contractility of mouse aorta: A link to autonomic dysfunction in Parkinson's disease

Neurochemistry International

Volumn 56, Issue 8, 2010, Pages 991-998

  Marrachelli, Vannina G ^a   Miranda, Francisco J ^a   Alabadí, José A ^a   Milán, Miguel ^a   Cano Jaimez, Marifé ^a   Kirstein, Martina ^a   Alborch, Enrique ^a,b   Fariñas, Isabel ^a   Pérez Sánchez, Francisco ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Synuclein immunolocalization; Synuclein knockout and transgenic mice; Acetylcholine; Dopamine; Isometric contractility; Mouse aorta; Norepinephrine; Parkinson's disease; Sodium nitroprusside; Vascular function

Indexed keywords

ACETYLCHOLINE; ALPHA SYNUCLEIN; DOPAMINE; NITROPRUSSIDE SODIUM; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; VASODILATOR AGENT;

ANIMAL TISSUE; AORTA MEDIA; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOPAMINE RELEASE; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; MUSCLE CELL; NERVE FIBER; NONHUMAN; NORADRENALIN RELEASE; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SMOOTH MUSCLE CONTRACTILITY; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASCULAR RING; VASOCONSTRICTION; VASODILATATION;

ALPHA-SYNUCLEIN; ANIMALS; AORTA, THORACIC; AUTONOMIC NERVOUS SYSTEM DISEASES; ENDOTHELIAL CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PARKINSON DISEASE; PRESYNAPTIC TERMINALS; SYMPATHETIC FIBERS, POSTGANGLIONIC; VASOCONSTRICTION;

MURINAE; MUS; MUS MUSCULUS;

EID: 77952875499     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.04.011     Document Type: Article

References (57)

1. Abeliovich A., Schmitz Y., Fariñas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., Rosenthal A. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
2. Al-Wandi A., Ninkina N., Millership S., Williamson S.J., Jones P.A., Buchman V.L. Absence of α-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice. Neurobiol. Aging 2010, 31:796-804.
3. Amino T., Orimo S., Itoh Y., Takahashi A., Uchihara T., Mizusawa H. Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol. 2005, 15:29-34.
4. Archer T., Fredriksson A. Influence of noradrenaline denervation on MPTP-induced deficits in mice. J. Neural Transm. 2006, 113:1119-1129.
5. Barbic F., Perego F., Canesi M., Gianni M., Biagiotti S., Costantino G., Pezzoli G., Porta A., Malliani A., Furlan R. Early abnormalities of vascular and cardiac autonomic control in Parkinson's disease without orthostatic hypotension. Hypertension 2007, 49:120-126.
6. Barbour R., Kling K., Anderson J.P., Banducci K., Cole T., Diep L., Fox M., Goldstein J.M., Soriano F., Seubert P., Chilcote T.J. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener. Dis. 2008, 5:55-59.
7. Braak H., Del Tredici K., Rüb U., de Vos R.A.I., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
8. Braak H., Del Tredici K. Nervous system pathology in sporadic Parkinson's disease. Neurology 2008, 70:1916-1925.
9. Braak H., Del Tredici K. Cortico-basal ganglia cortical circuitry in Parkinson's disease reconsidered. Exp. Neurol. 2008, 212:226-229.
10. Cabin D.E., Shimazu K., Murphy D., Cole N.B., Gottschalk W., McIlwain K.L., Orrison B., Chen A., Ellis C.E., Paylor R., Lu B., Nussbaum R.L. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking α-synuclein. J. Neurosci. 2002, 22:8797-8807.
11. Cano-Jaimez M., Pérez-Sánchez F., Milán M., Buendía P., Ambrosio S., Fariñas I. Vulnerability of peripheral catecholaminergic neurons to MPTP is not regulated by α-synuclein. Neurobiol. Dis. 2010, 38:92-103.
12. Cookson M.R. α-Synuclein and neuronal cell death. Mol. Neurodegenation 2009, 4(9). 10.1186/1750-1326-4-9.
13. Duran R., Barrero F.J., Morales B., Luna J.D., Ramirez M., Vives F. Plasma α-synuclein in patients with Parkinson's disease with and without treatment. Movement Disord. 2010, 15:489-493.
14. El-Agnaf O.M., Salem S.A., Paleologou K.E., Cooper L.J., Fullwood N.J., Gibson M.J., Curran M.D., Court J.A., Mann D.M., Ikeda S., Cookson M.R., Hardy J., Allsop D. α-Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J. 2003, 17:1945-1947.
15. El-Agnaf O.M., Salem S.A., Paleologou K.E., Curran M.D., Gibson M.J., Court J.A., Schlossmacher M.G., Allsop D. Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J. 2006, 20:419-425.
16. Farley I.J., Hornykiewicz O. Noradrenaline in subcortical brain regions of patients with Parkinson's disease and control subjects. Advances in Parkinsonism 1976, 178-185. Editiones Roche, Basel. W. Birkmayer, O. Hornykiewicz (Eds.).
17. Fuchs J., Tichopad A., Golub Y., Munz M., Schweitzer K.J., Wolf B., Berg D., Mueller J.C., Gasser T. Genetic variability in the SNCA gene influences α-synuclein l. FASEB J. 2008, 22:1327-1334.
18. Fujishiro H., Frigerio R., Burnett M., Klos K.J., Josephs K.A., Delledonne A., Parisi J.E., Ahlskog J.E., Dickson D.W. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Movement Disorders 2008, 15:1085-1092.
19. 125I-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced parkinsonism. Nuclear Med. Biol. 2006, 33:37-42.
20. Gesi M., Soldani P., Giorgi F.S., Santinami A., Bonaccorsi I., Fornai F. The role of the locus coeruleus in the development of Parkinson's disease. Neurosci. Biobehav. Rev. 2000, 24:655-668.
21. Ghebremedhin E., Del Tredici K., Langston J.W., Braak H. Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study. Acta Neuropathol. 2009, 118:777-784.
22. Goldstein D.S. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol. 2003, 2:669-676.
23. Goldstein D.S., Eldadah B.S., Holmes C., Pechnik S., Moak J., Saleem A., Sharabi Y. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension 2005, 46:333-339.
24. Goldstein D.S., Sharabi Y., Karp B.I., Bentho O., Saleem A., Pacak K., Eisenhofer G. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clin. Autonomic Res. 2007, 17:118-121.
25. Iwanaga K., Wakabayashi K., Yoshimoto M., Tomita I., Satoh H., Takashima H., Satoh A., Seto M., Tsujihata M., Takahashi H. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999, 12:1269-1271.
26. Jellinger K.A. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Acta Neuropathol. 2003, 105:415-419.
27. Kaufmann H., Nahm K., Purohit D., Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 2004, 6:1093-1095.
28. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J.T., Schöls L., Riess O. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 1998, 18:106-108.
29. Lee J.M., Park K.W., Seo W.K., Park M.H., Han C., Jo I., Ahn Jo S. Carotid intima-media thickness in Parkinson's disease. Movement Disorders 2007, 22:2446-2449.
30. Li S.T., Dendi R., Holmes C., Goldstein D.S. Progressive loss of cardiac sympathetic innervation in Parkinson's disease. Ann. Neurol. 2002, 52:220-223.
31. Miller D.W., Hague S.M., Clarimon J., Baptista M., Gwinn-Hardy K., Cookson M.R., Singleton A.B. α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 2004, 62:1835-1838.
32. Mosharov E.V., Staal R.G.W., Bove J., Prou D., Hananiya A., Markov D., Poulsen N., Larsen K.E., Candace M.H., Moore M.H., Troyer M.D., Edwards R.H., Przedborski S., Sulzer D. α-Synuclein overexpression increases cytosolic catecholamine concentration. J. Neurosci. 2006, 26:9304-9311.
33. Mukaetova-Ladinska E.B., Milne J., Andras A., Abdel-All Z., Cerejeira J., Greally E., Robson J., Jaros E., Perry R., McKeith I.G., Brayne C., Xuereb J., Cleghorn A., Doherty J., McIntosh G., Milton I. α- and γ-Synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes. Dementia Geriatric Cognit. Disord. 2008, 26:32-42.
34. Nakai M., Fujita M., Waragai M., Sugama S., Wei J., Akatsu H., Ohtaka-Maruyama C., Okado H., Hashimoto M. Expression of α-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage. Biochem. Biophys. Res. Commun. 2007, 358:104-110.
35. Nemani V.M., Lu W., Berge V., Nakamura K., Onoa B., Lee M.K., Chaudhry F.A., Nicoll R.A., Edwards R.H. Increased expression of α-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 2010, 14:66-79.
36. Norris E.H., Giasson B., Lee I., -Y V.M. α-Synuclein: normal function and role in neurodegenerative diseases. Curr. Top. Dev. Biol. 2004, 60:17-54.
37. Oka H., Mochio S., Onouchi K., Morita M., Yoshioka M., Inoue K. Cardiovascular dysautonomia in de novo Parkinson's disease. J. Neurol. Sci. 2006, 241:59-65.
38. Orimo S., Uchihara T., Nakamura A., Mori F., Kakita A., Wakabayashi K., Takahashi H. Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008, 131:642-650.
39. Orimo S., Uchihara T., Nakamura A., Mori F., Ikeuchi T., Onodera O., Nishizawa M., Ishikawa A., Kakita A., Wakabayashi K., Takahashi H. Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication. Acta Neuropathol. 2008, 116:575-577.
40. Pérez-Sánchez F., Milán M., Buendía P., Cano-Jaimez M., Ambrosio S., Fariñas I. Prosurvival effect of human wild-type α-synuclein on MPTP-induced toxicity to central but not peripheral catecholaminergic neurons isolated from transgenic mice. Neuroscience 2010, 167:261-276.
41. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
42. Rommelfanger K.S., Edwards G.L., Freeman K.G., Liles L.C., Miller G.W., Weinshenker D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13804-13809.
43. Ryan M.J., Didion S.P., Davis D.R., Faraci F.M., Sigmund C.D. Endothelial dysfunction and blood pressure variability in selected inbred mouse strains. Arteriosclerosis Thrombosis Vascular Biol. 2002, 22:42-48.
44. Scherzer C.R., Grass J.A., Liao Z., Pepivani I., Zheng B., Eklund A.C., Ney P.A., Ng J., McGoldrick M., Mollenhauer B., Bresnick E.H., Schlossmacher M.G. GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10907-10912.
45. Seniuk N.A., Tatton W.G., Greenwood C.E. Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Brain Res. 1990, 27:7-20.
46. Sharabi Y., Imrich R., Holmes C., Pechnik S., Goldstein D.S. Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension. Movement Disord. 2008, 23:1725-1732.
47. Shin E.C., Cho S.E., Lee D.K., Hur M.W., Paik S.R., Park J.H., Kim J. Expression patterns of α-synuclein in human hematopoietic cells and in Drosophila at different developmental stages. Molecules Cells 2000, 10:65-70.
48. Singleton A., Gwinn-Hardy K., Sharabi Y., Li S.T., Holmes C., Dendi R., Hardy J., Singleton A., Crawley A., Goldstein D.S. Association between cardiac denervation and parkinsonism caused by α-synuclein gene triplication. Brain 2004, 127:768-772.
49. Sotiriou E., Vassilatis D.K., Vila M., Stefanis L. Selective noradrenergic vulnerability in alpha-synuclein transgenic mice. Neurobiol. Aging 2009, 10.1016/j.neurobiolaging.2008.11.010.
50. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. α-Synuclein in Lewy bodies. Nature 1997, 388:839-840.
51. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 1998, 251:205-208.
52. Tamo W., Imaizumi T., Tanji K., Yoshida H., Mori F., Yoshimoto M., Takahashi H., Fukuda I., Wakabayashi K., Satoh K. Expression of α-synuclein, the precursor of non-amyloid beta component of Alzheimer's disease amyloid, in human cerebral blood vessels. Neurosci. Lett. 2002, 326:5-8.
53. Turkka J.T. Correlation of the severity of autonomic dysfunction to cardiovascular reflexes and to plasma noradrenaline levels in Parkinson's disease. Eur. Neurol. 1987, 26:203-210.
54. Yavich L., Tanila H., Vepsalainen S., Jäkälä P. Role of α-synuclein in presynaptic dopamine recruitment. J. Neurosci. 2004, 24:11165-11170.
55. Yavich L., Oksman M., Tanila H., Kerokoski P., Hiltunen M., van Groen T., Puolivali J., Mannisto P.T., Garcia-Horsman A., MacDonald E., Beyreuther K., Hartmann T., Jäkälä P. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein. Neurobiol. Disease 2005, 20:303-313.
56. Yavich L., Jäkälä P., Tanila H. Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in α-synuclein knockout and A30P transgenic mice. J. Neurochem. 2006, 99:724-732.
57. Zarranz J.J., Alegre J., Gómez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodríguez O., Atarés B., Llorens V., Gómez-Tortosa E., del Ser T., Muñoz D.G., de Yébenes J.G. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 2004, 55:164-173.